title: Continuous administration of linezolid in pneumonia: what is the level of proof?
authors.affiliation: CHU de Poitiers, Service d'Anesthésie Réanimation, Université de Poitiers, INSERM U1070, Poitiers, France, o.mimoz@chu-poitiers.fr.
authors.forename: Olivier
authors.initials: O
authors.lastname: Mimoz
authors.forename: Philippe
authors.initials: P
authors.lastname: Montravers
authors.forename: José-Artur
authors.initials: JA
authors.lastname: Paiva
mesh_terms: D000081:Acetamides / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D015897:Comorbidity; D016638:Critical Illness; D006801:Humans; D007262:Infusions, Intravenous; D007362:Intensive Care Units; D000069349:Linezolid; D008826:Microbial Sensitivity Tests; D023303:Oxazolidinones / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011014:Pneumonia / Q000188:drug therapy*
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid